Meridian Bioscience Announces FDA Clearance for Innovative Curian® Shiga Toxin Assay
CINCINNATI, OHIO, April 19, 2023 (PRNewswire) – Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that the United States Food and Drug Administration (FDA) had granted clearance for the company’s new Curian® Shiga Toxin assay. This assay joins Curian HpSA® and Curian Campy as Meridian […]
Meridian Bioscience Comments on DOJ Announcement Regarding Former Executives of Magellan Diagnostics
CINCINNATI, April 5, 2023 /PRNewswire/ — Meridian Bioscience, Inc. learned today that certain former employees of Magellan, a subsidiary of Meridian acquired in March 2016, were charged by the United States Attorney for the District of Massachusetts for alleged violations of certain federal laws. Meridian and its subsidiaries are not defendants in the action. As previously disclosed, Meridian and Magellan have cooperated […]
SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience
CINCINNATI, OHIO & SEOUL, SOUTH KOREA, January 31, 2023 (PRNewswire) – Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, and SD Biosensor, Inc. (“SDB”) (KOSE: A137310) and SJL Partners LLC (“SJL”) (collectively, the “Consortium”), announced today that they have completed the transaction to acquire Meridian. […]